Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knipp, S
Right arrow Articles by Gattermann, N
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knipp, S
Right arrow Articles by Gattermann, N
Haematologica, Vol 90, Issue 5, 691-693
Copyright © 2005 by Ferrata Storti Foundation

Letter

Secondary myelodysplastic syndromes following treatment with azathioprine are associated with aberrations of chromosome 7

S Knipp, B Hildebrandt, J Richter, R Haas, U Germing, and N Gattermann

We report 14 cases of secondary myelodysplastic syndromes (sMDS) following treatment with azathioprine for non-malignant disorders. Long-term treatment with azathioprine seems to be associated with an increased risk of MDS and subsequent leukemic transformation.




HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2005 by the Ferrata Storti Foundation.